Emergent BioSolutions: Solid Q3, Expecting Better Days To Come
Source: SeekingAlpha
2025-11-06 23:00:37 ET
Investment Overview
In my last note on Emergent Biosciences ( EBS ) for Seeking Alpha in June, I reiterated the "Buy" call made in a note dated 8th November 2024 , when stock traded at $11 per share....
Read the full article on Seeking Alpha
For further details see:
Emergent BioSolutions: Solid Q3, Expecting Better Days To Come
Emergent Biosolutions Inc.
NASDAQ: EBS
EBS Trading
-0.06% G/L:
$8.065 Last:
212,002 Volume:
$8.23 Open:
EBS Latest News
March 03, 2026 08:00:00 am
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors
February 26, 2026 04:05:00 pm
Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026 04:01:00 pm
Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada, Strengthening Canada's Leadership in Health Preparedness
February 26, 2026 04:01:00 pm
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program
EBS Stock Data
$592,950,394
50,839,325
1.42%
58
N/A
Pharmaceuticals
Healthcare
US
Gaithersburg
